Moreover, SIPA1 was shown to alter glucose metabolism, leading to breast cancer progression [24], and to aggravate the malignancy of breast cancer by enhancing MYH9 in extracellular vesicles [25]. This evidence concerns the gene SIPA1 and breast carcinoma.